Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 2,198,237 | 1,901,979 | 1,243,336 | 933,013 | 701,887 |
| Cost of Goods | 839,605 | 319,099 | 150,343 | 139,989 | 97,049 |
| Gross Profit | 1,358,632 | 1,582,880 | 1,092,993 | 793,024 | 604,838 |
| Operating Expenses | 2,059,018 | 1,364,898 | 1,361,160 | 1,330,214 | 1,064,597 |
| Operating Income | -699,781 | 218,081 | -267,824 | -536,201 | -459,710 |
| Other Income | -2,444 | 42,693 | -252,274 | -153,762 | 40,762 |
| Pre-tax Income | -702,225 | 260,774 | -520,098 | -689,963 | -418,948 |
| Income Tax | 11,185 | 25,535 | 15,879 | 13,525 | -168 |
| Net Income Continuous | -713,410 | 235,239 | -535,977 | -703,488 | -418,780 |
| Net Income | $-713,410 | $235,239 | $-535,977 | $-703,488 | $-418,780 |
| EPS Basic Total Ops | -7.13 | 2.47 | -5.80 | -8.03 | -5.15 |
| EPS Basic Continuous Ops | -7.13 | 2.47 | -5.80 | -8.03 | -5.15 |
| EPS Diluted Total Ops | -7.13 | 2.34 | -5.80 | -8.03 | -5.15 |
| EPS Diluted Continuous Ops | -7.13 | 2.18 | -5.80 | -8.03 | -5.15 |
| EPS Diluted Before Non-Recurring Items | -6.29 | 2.34 | -5.80 | -8.03 | -5.15 |
| EBITDA(a) | $-660,551 | $215,528 | $-269,603 | $-504,988 | $-421,795 |